Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioPorto Diagnostics AS

www.bioporto.com

Latest From Teva Neuroscience Inc.

Rx Drug Promotion Risks: Value Claims, Getting Close To Patients

Comparative claims to distinguish a product are triggering FDA enforcement letters; companies also face risks when interacting more with patients.

BioPharmaceutical United States

Specialty Rx Use Higher In Exchanges Than Commercial Plans – Express Scripts

Express Scripts analysis of pharmacy claims from the first two months of Affordable Care Act exchange plan operations show members of those plans are prescribed specialty drugs 47% more often than members of commercial plans.

BioPharmaceutical United States

Biosimilar Patent Strategy: Follow-Ons May Target Secondary, Third Party Patents

Initial applicants could establish solid precedents in courts and at FDA – to the benefit of subsequent competitors.

BioPharmaceutical United States

FDA Enforcement Letters On Rx Drug Promotions Plummet In 2013

OPDP Director Tom Abrams cautions against reading into the “snapshot.”

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • BioPorto Diagnostics AS
  • Senior Management
  • Peter Morch Eriksen, CEO
    Jakob Brix Christensen, CFO
    Jan Kuhlmann Andersen, COO
  • Contact Info
  • BioPorto Diagnostics AS
    Phone: 4529 000
    Tuborg Havnevej 15, st
    Gentofte, DK-2900
    Denmark
Advertisement
Advertisement
UsernamePublicRestriction

Register